CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lifecore Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lifecore Biomedical Inc
3515 Lyman Boulevard
Phone: (952) 368-4300p:952 368-4300 CHASKA, MN  55318  United States Ticker: LFCRLFCR
Business Summary
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes--Yes

Industries
SIC Code Description
2821 Plastics materials, synthetic resins, and nonvulcanizable elastomers
2834 Pharmaceutical preparations
2079 Shortening, table oils, margarine, and other edible fats and oils
5169 Chemicals and allied products, not elsewhere classified
5153 Grain and field beans
2891 Adhesives and sealants
8731 Commercial physical and biological research
2033 Canned fruits, vegetables, preserves, jams, and jellies
2099 Food preparations, not elsewhere classified
2037 Frozen fruits, fruit juices, and vegetables

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Katrina L.Houde 67 11/1/2024 8/5/2019
President, Chief Executive Officer, Director PaulJosephs 60 5/20/2024 5/20/2024
Chief Financial Officer Ryan D.Lake 47 9/3/2024 9/3/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Apio, Inc. 4575 West Main St. Guadalupe CA United States
Curation Foods, Inc. 2811 Airpark Dr Santa Maria CA United States
LANDEC AG, INC. 201 N MICHIGAN ST OXFORD IN
GreenLine Foods, Inc. 8600 S Wilkinson Way Perrysburg OH United States

Business Names
Business Name
Apio, Inc.
Camden Fruit Corp
GreenLine Foods, Inc.
8 additional Business Names available in full report.

General Information
Number of Employees: 382 (As of 12/31/2025)
Outstanding Shares: 37,477,386 (As of 12/31/2025)
Shareholders: 49
Stock Exchange: NASD
Federal Tax Id: 943025618
Fax Number: (302) 636-5454
Email Address: spowell@landec.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026